Pharmafile Logo
Pharmafocus logo
Advanced Search
janssen image

FDA approves Olysio

November 25, 2013
Sales and Marketing FDA, Janseen, Janssen, hep C, hepc, olysio, simeprevir

US regulators have approved Janssen Pharmaceuticals’ Olysio, a new therapy to treat chronic hepatitis C virus infection, after a priority …

News

Patient involvement ‘increases public confidence’ in research

November 25, 2013
Research and Development, Sales and Marketing hra, mori, public, rec, research

A new study has shown that public confidence in health research studies can be increased by knowing that patients have …

News
talent_pipeline

Hold your horses: M&A is about talent, not just pipelines

November 25, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing M&A, MA, mergers, molloy, roik, rsa, talent

The morning mist is rising on the battlefield. At stake: the crown riches and glory of tomorrow’s pharma leadership. The …

Feature

Camargo Pharmaceutical Services names chief operating officer

November 25, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Camargo Pharmaceutical Services

Veteran healthcare executive Jim Beach has been named chief operating officer for drug development firm Camargo Pharmaceutical Services. “Jim’s history …

Appointment

Gilead gets CHMP nod

November 25, 2013
Research and Development, Sales and Marketing CHMP, FDA, Gilead, chc, sovaldi

The CHMP has opened the way for Gilead Sciences’ first-in-class investigational chronic hepatitis C drug Sovaldi (sofosbuvir) to get to …

News

Pfizer says it will close Puerto Rico plant

November 22, 2013
Manufacturing and Production Guayama, Humacao, Pfizer, Puerto Rico, Vega Baja

News
NHS image

E-prescribing ‘patchy at best’

November 22, 2013
Medical Communications, Sales and Marketing DoH, NHS, UCL, e-prescribing

Electronic prescribing in NHS hospitals – seen as one of the cornerstones of public health provision in the future – …

News

Cancer app takes top prize in Janssen digital awards

November 22, 2013
Medical Communications, Sales and Marketing Cancer, J&J, JJ, app, digital, px healthcare

A start-up firm established by medical scientists that develops mobile apps for cancer patients has taken first place in the …

News

Big data ‘road map’ launched by ABPI

November 22, 2013
Medical Communications, Research and Development, Sales and Marketing ABPI, BMA, NIHR, data, transparency

The ABPI has launched a new initiative that aims to harness the potential of big data to improve patient care …

News
screen_shot_2013-11-22_at_08

Life makes several changes

November 22, 2013
Medical Communications, Research and Development, Sales and Marketing Life, comms, creative, healthcare

Marketing communications firm Life is restructuring to advance its status as an integrated creative company. As part of this process …

Appointment
Department of health

Coalition launches rare disease strategy

November 22, 2013
Research and Development, Sales and Marketing DoH, NHS, R&D, rare disease

The Department of Health has launched the UK’s first strategy on rare diseases as part of a bid to boost …

News
lilly image

Lilly signs Lou Gehrig’s disease deal

November 21, 2013
Research and Development, Sales and Marketing als, hill, lilly, lou gehrig

Eli Lilly & Company has signed a deal with US charity Project A.L.S. to find new treatments for the debilitating …

News
GSK image

GSK makes £425 million Aspen sale

November 21, 2013
Sales and Marketing GSK, Merck, South Africa, aspen

GlaxoSmithKline has raised £425 million with the sale of 28.2 million shares that it has in Africa’s biggest drugmaker as …

News
brain in hand image

Smartphone app to aid brain injury sufferers

November 21, 2013
Medical Communications brain, brain in hand, digital, glenside, smartphone, wells

Neurological rehabilitation firm Glenside are running a large-scale pilot which uses smartphone technology to improve the lives of people with …

News
Mid staffs image

NHS responds to Mid Staffs

November 21, 2013
Sales and Marketing Francis, Mid Staffs, NHS, UK

The government has accepted 281 out of the 290 recommendations contained in the Francis report – the damning document published …

News
screen_shot_2013-11-21_at_08

Novasep appoints president of Industrial Biotech business

November 21, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novasep

French processing equipment supplier Novasep has appointed Nadege Laborde as the new president of its Industrial Biotech business unit. It …

Appointment
Prescriptions image

Global prescriptions cost to hit $1 trillion

November 20, 2013
Medical Communications, Research and Development, Sales and Marketing IMS, UK, prescriptions

The worldwide cost of medicine prescriptions will for the first time hit $1 trillion next year as drugs get more …

News
EMA image

EMA looks to sharpen HTA data output

November 20, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EMA, NICE, hta, transparency

The European Medicines Agency (EMA) has deepened its partnership with the European network for Health Technology Assessment (EUnetHTA) as it …

News
rory_shaw_nhs

Healthcare UK appoints medical director

November 20, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, healthcare uk

Professor Rory Shaw has been hired as the medical director of Healthcare UK to lead the newly-established NHS International Development …

Appointment
Vimovo image

AstraZeneca sells arthritis drug for $35 million

November 20, 2013
Sales and Marketing AstraZeneca, RA, arthritis, horizon, vimovo

AstraZeneca has sold rights to its arthritis treatment Vimovo to speciality pharma firm Horizon Pharma for $35 million.  AZ retains …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026